Iterion Therapeutics Makes Significant Progress with Tegavivint in Colorectal Cancer Treatments Iterion Therapeutics has announced the dosing of the first patient in a clinical trial for its innovative treatment Tegavivint against colorectal cancer, marking a critical advancement in cancer therapy.

Iterion Therapeutics Makes Significant Progress with Tegavivint in Colorectal Cancer Treatments #USA #Houston #Iterion_Therapeutics #Tegavivint #Wnt_Inhibitor

Iterion Therapeutics Begins Clinical Trial for Innovative Osteosarcoma Treatment Using Tegavivint Iterion Therapeutics has commenced a clinical trial to assess tegavivint, a pioneering drug aimed at treating relapsed osteosarcoma, promising innovative advancements in cancer therapy.

Iterion Therapeutics Begins Clinical Trial for Innovative Osteosarcoma Treatment Using Tegavivint #Houston #US #Osteosarcoma #Iterion_Therapeutics #Tegavivint